SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The disclosure centers on the election of Tali Farhadian Weinstein to the Board of Directors of Consolidated Edison, Inc. and Consolidated Edison Company of New York, Inc., effective July 1, 2026. She was also appointed to two board committees. This is a clear board appointment, which is a material governance event affecting the composition of the registrant's leadership.
View raw filing on EDGAR →Francis A. Braun III and Dylan G. Petre were appointed to the Board of Directors effective July 1, 2026 upon listing, with Braun designated as Audit Committee chair and Petre appointed to the Nominating and Corporate Governance Committee.
View raw filing on EDGAR →Michael Blitzer was appointed as director and Chairman of the Board, and Kevin Shannon was appointed as Chief Executive Officer, both effective June 26, 2026, in connection with the Business Combination Agreement with Inflection Point Asset Management LLC.
View raw filing on EDGAR →Dr. Craig Eagle was appointed to OS Therapies' Board of Directors effective June 1, 2026, transitioning from Chief Medical Advisor. Dr. Eagle brings substantial oncology and pharmaceutical leadership experience, including prior roles as CMO at Guardant Health, VP Medical Affairs at Genentech, and senior positions at Pfizer.
View raw filing on EDGAR →The Board appointed Joanna Lohkamp as an interim director, Audit Committee member, and Remuneration Committee chair, effective July 1, 2026. This is a clear executive/board appointment that would materially affect investor assessment of the company's governance and leadership structure, particularly given her committee roles overseeing audit and compensation matters.
View raw filing on EDGAR →The filing discloses both the resignation of Mark Pickering as CFO and Executive Officer (effective June 29, 2026) and the appointment of Carrie Rosorea as CFO and Executive Officer on the same date. While both events occur, the principal disclosed action is the appointment of a new CFO to fill the vacancy, making exec_appointment the primary classification. CFO changes are material to investors assessing management continuity and financial oversight.
View raw filing on EDGAR →Dr. David S. Shields was appointed as a Class I director and Compensation Committee member of CapsoVision, Inc., effective July 1, 2026, bringing deep clinical expertise in capsule endoscopy to the Board. The appointment also coincided with Dr. Joanne Imperial's resignation from the Board.
View raw filing on EDGAR →The disclosure centers on the Board's appointment of Elizabeth Hurlburt to a newly created role of Chief Operating and Commercial Officer with expanded functional oversight of commercial functions, medical affairs, regulatory and clinical. While Michael Seckler's departure is mentioned, the principal action disclosed is Hurlburt's appointment to an expanded executive position. The expansion of her role and new title constitute a material change in executive leadership structure.
View raw filing on EDGAR →Matthew S. Diffley was appointed as Principal Accounting Officer (PAO) of Live Oak Bancshares, Inc., effective July 1, 2026, replacing interim PAO Walter J. Phifer. While the disclosure also mentions an expected RSU grant of $200,000, the principal disclosed action is the appointment of a named executive to a key officer role. The appointment of a PAO is material to investors as it affects the registrant's financial reporting and internal controls oversight.
View raw filing on EDGAR →The 6-K discloses the appointment of Mr. Tee Kok Siong as Chief Financial Officer of Ryde Group Ltd, effective July 3, 2026, to fill the vacancy created by Mr. Lang Chen Fei's resignation. While both a departure and appointment occur, the principal disclosed action is the appointment of a named executive to a C-suite officer role, which is material to investors assessing the company's financial leadership and governance. The detailed biographical information and professional qualifications provided underscore the materiality of this executive transition.
View raw filing on EDGAR →The filing discloses the appointment of two directors, Danina Fisher and Gary S. Stetz, II, to the Board of Directors of Hepion Pharmaceuticals, effective immediately on July 1, 2026. This is a clear executive appointment under Item 5.02, with the principal disclosed action being persons taking board roles. The disclosure notes a family relationship between Mr. Stetz and Gary Stetz (the interim CEO signing the filing), which adds governance significance.
View raw filing on EDGAR →UPAY, Inc. appointed Wynand Johannes Jordaan as a non-executive director effective July 1, 2026. The appointment includes a compensatory arrangement of 200,000 restricted shares vesting over 24 months and is intended to strengthen the board's technology, software architecture, systems design, and digital infrastructure expertise.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →Lucid announced multiple senior executive appointments to its Global Leadership Team, including Alexander De Bock as Chief Financial Officer (with $750,000 base salary, $1.1M signing bonus, $7.5M equity grants, and up to $2.5M performance-based bonuses), Raja Ramana Macha as Chief Technology Officer, Billy Hayes as Chief Customer Officer, Hugo Martinho as Chief Transformation Officer, Kay Stepper as Chief Digital Officer, and a promotion of Christian Appel, alongside the departure of incumbent CFO Taoufiq Boussaid. These appointments are intended to simplify the organization, sharpen accountability, and improve execution.
View raw filing on EDGAR →The filing discloses multiple executive appointments effective July 1, 2026: Robert Wright appointed Chief Financial Officer (replacing Mark Hobbs), Misty Lavender appointed Executive Vice President, General Counsel and Corporate Secretary (replacing Denise McWatters), and Mohit Bhardwaj appointed to a new Executive Vice President, New Energy role. While the section also includes compensation amendments and a departure (McWatters transitioning to consulting), the principal disclosed actions center on the appointments of new officers to key leadership positions, making exec_appointment the most salient classification.
View raw filing on EDGAR →The press release announces the appointment of Marvin Singer to the board of directors as the representative for Ataraxia Capital, pursuant to an Investor's Rights Agreement. This is a clear executive/governance appointment of a director with relevant experience in corporate law, M&A, and corporate governance. Board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →Simon Kearney was elected to Nixxy's Board of Directors on June 29, 2026. The disclosure centers on his appointment as a director and includes his background, compensation structure (50,000 initial shares, annual equity grants, and $2,500 monthly payment), and confirmations of no conflicts or family relationships. This is a clear director appointment event.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointments of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointment of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the fund manager) on an interim basis, effective July 2, 2026, with Masci also appointed to the Board of Managers and as Principal Financial and Accounting Officer of the registrant. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointments of two executives to critical financial leadership roles. This is material as it affects the fund's financial oversight and reporting structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as CFO appointments directly affect investor confidence in financial reporting and governance.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointment of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses two director-level events: the resignation of Dr. Ming-Fu Chiang on June 27, 2026, and the election of Nasim Shomali as a Class II director on July 1, 2026. While both events are disclosed, the principal action emphasized in the Item 5.02 disclosure is the appointment of Shomali, which includes detailed biographical information and her effective date. The resignation is noted as non-contentious and without disagreement. The appointment of a new director to the board is a material governance event affecting the composition of the Company's leadership and oversight structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →Six Flags appointed Mark Pauls as Chief Operating Officer effective July 15, 2026, succeeding Tim Fisher. Pauls' compensation package includes a $600,000 base salary and $1,560,000 annual equity grant target, with comprehensive severance provisions.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's principal financial officer and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointment of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC (the sponsor) on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the two new appointments to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →The filing discloses the appointment of Kathryn Masci and Daniel Plourde as Co-Chief Financial Officers of Grayscale Investments Sponsors, LLC on an interim basis, effective July 2, 2026, with Ms. Masci also appointed as Principal Financial and Accounting Officer of the registrant and as a member of the Board of Managers. While the filing also mentions Edward McGee's departure, the principal disclosed action centers on the appointment of two named executives to critical financial leadership roles. This is material as it affects the registrant's financial reporting and governance structure.
View raw filing on EDGAR →Andrew D. Walker has been promoted to Executive Vice President, Chief Customer Operations Officer, representing a material elevation in title and scope of responsibility within the company's executive leadership. The disclosure emphasizes his expanded portfolio of operational and transformation functions, making this a significant executive appointment that would affect a reasonable investor's assessment of the company's leadership structure and operational direction.
View raw filing on EDGAR →Williams Companies appointed two independent directors, Robb E. Turner and Lloyd W. (Billy) Helms, Jr., to its Board of Directors effective July 1, 2026, expanding the Board from ten to twelve members. Both appointees will receive annual compensation of $130,000 in cash retainer and $200,000 in RSU equity retainer.
View raw filing on EDGAR →Rocco F. Arcuri, Sr. was appointed as a director of Arrow Financial Corporation and as Senior Vice President, Regional President, Mohawk Valley of Arrow Bank, effective July 1, 2026, following the completion of the Adirondack acquisition. The appointment reflects leadership integration from the acquired entity.
View raw filing on EDGAR →Nathan E. Baxter was appointed President & Chief Executive Officer effective June 26, 2026, and elected to the Board of Directors. While the filing also discloses James Hagedorn's departure as CEO and Chairman (and his severance arrangements), the principal disclosed action centers on Baxter's appointment to the top executive role and board seat, which is the forward-looking leadership change. The appointment is material as it represents a significant succession event at the company's helm after Hagedorn's 25-year tenure as CEO.
View raw filing on EDGAR →The Board appointed Damian A. Ribar as Executive Vice President and Chief Operating Officer, effective July 20, 2026. While the disclosure includes compensatory details (base salary of $500,000, equity awards, and bonus eligibility), the principal disclosed action is the appointment of a named executive officer to a C-suite role. The compensation terms are ancillary to the appointment itself.
View raw filing on EDGAR →Ramesh Srinivasan was appointed to the executive officer position of Executive Vice President, Chief Strategy Officer, effective August 1, 2026.
View raw filing on EDGAR →The filing discloses the appointment of Bruce Hausmann as a director of Mativ Holdings, effective July 1, 2026, to fill a newly created board vacancy. The Board increased from 6 to 7 members and appointed Hausmann as a Class I director with a term expiring at the 2029 Annual Meeting. He was also appointed to the Audit Committee and qualifies as an "audit committee financial expert." This is a clear executive appointment event, material to investors as it affects board composition and governance.
View raw filing on EDGAR →The disclosure centers on the appointment of Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer of Rigel Pharmaceuticals, effective July 1, 2026. While the filing also mentions Dr. Hannah's concurrent resignation from the Board and the departure of the prior CMO, Lisa Rojkjaer, the principal action disclosed is the appointment of a named executive officer to a C-suite position. This is material to investors as it affects the Company's senior leadership and medical strategy.
View raw filing on EDGAR →The filing discloses the appointment of Nnamdi Njoku as President of Omnicell, effective July 1, 2026, while retaining his COO role. Although the disclosure also mentions that Randall Lipps stepped down from the President role, the principal action disclosed is Njoku's appointment and promotion to President. The filing emphasizes his expanded responsibilities in shaping long-term growth strategy and operational execution, and includes a material equity award of approximately $500,000 in restricted stock units as part of the promotion.
View raw filing on EDGAR →QXO appointed Alec Covington as a director effective upon completion of the TopBuild Merger and appointed Madeline Otero as Interim Chief Accounting Officer effective July 1, 2026, with specified compensation including $400k base salary, $600k equity target, and $500k retention award.
View raw filing on EDGAR →The disclosure centers on John Vong's appointment as Senior Vice President – Accounting and his succession to the principal accounting officer role effective August 7, 2026, following Glenn Sobotka's retirement. While both a departure and appointment occur, the filing emphasizes Vong's appointment and qualifications, making the appointment the principal disclosed action. The change in the principal accounting officer is material to investors assessing the company's financial reporting oversight.
View raw filing on EDGAR →Uwe Breitweg, Vice President Powertrain, Emission and Battery Strategy of the BMW Group, was appointed as a Class III director of Solid Power effective July 1, 2026, pursuant to BMW Holding's director nomination rights. The appointment is material given Breitweg's two decades of automotive leadership, deep battery strategy expertise, and BMW's role as a key development partner.
View raw filing on EDGAR →Effective July 1, 2026, Mobility Global appointed a substantially reconstituted board of seven new directors (Eric W. Aboaf, William W. Eager, Heather Lavallee, Monique F. Leroux, Mark S. Peek, Shilpa Ranganathan, and Alexander Taussig), appointed Joseph R. Hinrichs as Chair, and appointed three new officers: Scott Fredericks as President of CARFAX, Joseph S. LaFeir as President of Mobility Business Solutions, and Renato Negro as Chief Accounting Officer. These appointments reflect the company's transition to independent public company status following its separation from S&P Global.
View raw filing on EDGAR →